Browse > Article
http://dx.doi.org/10.15204/jkobgy.2019.32.4.132

Analysis of the Characteristics and Treatment of Breast Cancer Patients in a Korean Medicine Hospital  

Kim, Gyu-Tae (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Hwang, Young-Sik (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Lee, Jin-Wook (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Park, Seung-Hyeok (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Jin-Moo (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Chang-Hoon (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Jang, Jun-Bock (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Hwang, Deok-Sang (Dept. of Gynecology, College of Korean Medicine, Kyung Hee University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.32, no.4, 2019 , pp. 132-143 More about this Journal
Abstract
Objectives: The purpose of this study is to provide basic information on Korean medical research and treatment through analysis of breast cancer patients, who visited ${\bigcirc}{\bigcirc}$ university Korean medicine hospital. Methods: To analyze characteristics of breast cancer patients who visited korean medicine hospital, we searched medical records from January 1, 2016 to May 13, 2019, and 86 breast cancer patients were analyzed. Results: 1. The general characteristics of the subjects are as follows. The average age was $47.65{\pm}9.62years$ and 40's was the most (46.51%). The average height was $159.78{\pm}4.91cm$ and the average weight was $57.29{\pm}9.34kg$. The average body mass index (BMI) of the patients was $22.40{\pm}3.50kg/m^2$. 2. The stage distribution record indicated stage０ (9.72%), stageI (31.94%), stageII (34.72%), stageIII (20.83%) and stageIV (2.78%). 14 patients with unknown stage were excluded. 3. Before coming to the korean medicine hospital, of the 86 patients, 72 (83.72%) patients received surgical therapy, 55 (63.95%) patients received chemotherapy and 44 (51.16%) patients received radiotherapy. 11 (12.79%) patients chose oriental medicine as their primary treatment option. 4. The mean duration from diagnosis to hospital visit was $13.87{\pm}15.53months$. Among the total 86 patients, 46 (53.49%) patients visited for symptom relief during the follow-up period. 5. The most common symptom was general weakness in 29 (33.72%) patients, followed by hot flash, myalgia, insomnia, digestion disorder, numbness, edema, arthralgia, operation site pain, cold sensation and mastalgia. 6. Among 86 patients, 55 (63.95%) patients received acupuncture and moxibustion together. The most prescribed herbal medicine to subjects was Sibjeondaebo-tang-gamibang and Cheonhye-dan (25%). Conclusions: These results could be helpful to provide basic data on the Korean medical approach of breast cancer patients.
Keywords
Breast Cancer; Characteristics; Korean Medical Treatment;
Citations & Related Records
Times Cited By KSCI : 13  (Citation Analysis)
연도 인용수 순위
1 Lee NH, et al. A Preliminary Study for Development of Clinical Practice Guidelines of Korean Medicine in Breast Cancer. J Korean Obstet Gynecol. 2016;29(2):47-65.   DOI
2 2018 Breast cancer white paper. Korean breast cancer society[cited May 29, 2019]. Available from URL:http://www.kbcs.or.kr/sub02/sub04.html.
3 National Cancer Registration Project Annual Report. National cancer center [cited May 29, 2019]. Available form URL:http://ncc.re.kr/cancerStatsList.ncc?sea.
4 Park KY, Kim MJ, Yang YO. Factors Relating to Quality of Life in Korean Breast Cancer Patients : Systematic Review and Meta-analysis. J Korean Acad Fundam Nurs. 2017;24(2):95-105.   DOI
5 Choi YJ, Lee JS, Cho SH. Use of Korean Medicine among Cancer Patients. J Korean Oriental Med. 2012;33(3):46-53.
6 Jeong HJ, et al. Clinical Characteristics Analysis of 58 Patients with Breast and Gynecologic Cancer in Oriental Hospital. J Physiol & Pathol Korean Med. 2014;28(5):571-5.
7 Choi JY, et al. Clinical Data Analysis of 106 Breast Cancer Patients Who Received Oriental Medical Treatment. J Korean Obstet Gynecol. 2008;21(4):228-36.
8 Korean Society of Obstetrics and Gynecology. Gynecology. 5th rev. Seoul:Golyeo-uihag. 2018:1001, 1018.
9 Park YA, Kim DC. Systemic Review on Complementary and Alternative Medicine for Breast Cancer. J Korean Obstet Gynecol. 2009;22(3):205-22.
10 Lee NH, et al. A Preliminary Study for Development of Clinical Practice Guidelines of Korean Medicine in Breast Cancer. J Korean Obstet Gynecol. 2016;29(2):47-65.   DOI
11 Kim NH, et al. A Survey on Treatment of Breast Cancer Patients with Korean Medicine: Preliminary Research for Clinical Practice Guidelines. J Korean Obstet Gynecol. 2018;31(4):165-78.   DOI
12 Han SA, et al. Experiences of Treatment -Related Side Effects and Supportive Care with Korean Medicine in Women with Breast Cancer - A Focus Group Study. J Korean Obstet Gynecol. 2017;30(1):85-94.   DOI
13 Kang SH, Chung KY, Kim YS. Analysis of Survival Rate and Prognostic Factors of 989 Patients with Breast Cancer. Korean Surg Soc. 2004;66(6):454-61.
14 An H, et al. Analysis of Risk Factors Affecting Breast Cancer Incidence : Breast Ultrasonography. J Korean Soc Radiol. 2017;11(4):298-305.
15 Huang Z, Yong EL. Ethnic Differences : Is There an Asian Phenotype for Polycystic Ovarian Syndrome? Best Practice & Research Clinical Obstetrics & Gynecology. 2016;37:46-55.   DOI
16 Lee AB, Moon BI. Chemotherapy in Breast Cancer. Ewha Med J. 2014;37(2):75-82.   DOI
17 Kim JM, et al. Pancytopenia Improves with Compromised Liver Function in A Hepatocellular Carcinoma Patient Treated by Modified Sipjeondaebo-tang. Korean J Orient Int Med. 2013;34(4):478-83.
18 Carpernter JS, et al. Hot flash in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, man-agement, and relation to quality of life. J Cancer. 1998;82(9):1682-91.   DOI
19 Heo J. Daeyeog Donguibogam. 1st ed. Seoul:Beob-in munhwasa. 2002:1176.
20 Oh SM, et al. The Analysis of the Recent Research Trend of Sipjeondabo -tang in Korea. Journal of Society of Preventive Korean Medicine. 2014;18(1):113-23.
21 Hur JC, et al. Antitumor Effect of the Cotreatment of Gagam-sibjeondaebo-tang and As2O3 in Human Lung Cancer Cell Line H-460. Korean J. Oriental Physiology & Pathology. 2004;18(4):1089-97.
22 Yang DS, Yang SJ. Effects of Curcuma longa L. on MDA-MB-231 Human Breast Cancer Cells and DMBA-induced Breast Cancer in Rats. J Korean Obstet Gynecol. 2013;26(3):44-58.   DOI
23 Hong SH, Park SE. Caspase-dependent and Akt-pathway Regulated Rhus Verniciflua Stokes Extract-induced Apoptosis in Human Breast Carcinoma MDA-MB-231 Cells. J Int Korean Med. 2017;38(4):409-18.   DOI
24 Heo J. Daeyeog Donguibogam.1st ed. Kyungnam:Donguibogam publisher. 2010:81.
25 So MS, Kim AR. Chemopreventive Activity of Astragali radix against Human Breast Cancer Cells. J Korean Health & Fundamental Med Sci. 2013;6(3):172-7.
26 Lee SM, et al. Jugyupsukgo-tang on Managing Symptoms Caused by Radiation Therapy in a Patient with Breast Cancer: a Case Report. J of Kor Traditional Oncology. 2013;18(1):23-31.   DOI
27 Jung HM, et al. Case Study of a Breast Cancer Patient Accompanying with Hot Flush by Tamoxifen Whose Condition was Improved by Jayeumganghwa-tang. Korean J Orient Int Med. 2010;31(2):395-400.